By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Eutropics Pharmaceuticals 

767-C Concord Avenue

Cambridge  Massachusetts  02138  U.S.A.
Phone: 617-714-4405 Fax: 617-714-4614



Company News
Eutropics Pharmaceuticals Signs $1.5M NCI Contract To Develop Predictive Diagnostic Tests For Guiding Acute Myeloid Leukemia Treatments 9/24/2014 9:02:21 AM
Tolero Pharmaceuticals And Eutropics Pharmaceuticals Announce Data Demonstrating Clinical Utility Of Praedicare Dx In Guiding New Drug Treatment Of CLL Patients 8/12/2014 11:02:05 AM
Eutropics Pharmaceuticals Laboratory Receives CLIA Certification 6/16/2014 9:25:43 AM
Eutropics Pharmaceuticals And Tolero Pharmaceuticals To Collaborate On Developing A Companion Diagnostic For Experimental Cancer Therapy 1/15/2014 8:42:53 AM
Eutropics Pharmaceuticals To Present Data On Personalized Diagnostic For Leukemia Patient Management At American Society of Hematology 2013 11/14/2013 9:41:16 AM
Eutropics Pharmaceuticals to Present Data on Personalized Diagnostic for AML Patient Management at American Society of Clinical Oncology 2013 5/16/2013 8:45:49 AM
Eutropics Pharmaceuticals Signs $1.5 Million National Cancer Institute/SBIR Contract to Develop Companion Diagnostic for Guiding Multiple Myeloma Treatments 9/21/2012 11:04:59 AM
Eutropics Pharmaceuticals Signs $1.5M NCI/SBIR Contract to Develop Companion Diagnostic for Guiding Multiple Myeloma Treatments 9/20/2012 11:10:10 AM
Eutropics Pharmaceuticals Awarded National Cancer Institute Contract to Develop Companion Diagnostic for Guiding AML Treatments 9/19/2012 10:16:46 AM
Eutropics Pharmaceuticals Receives U.S. Patent for Novel Diagnostic Method 5/8/2012 12:18:49 PM